Liver Disease Therapeutics Market By Treatment (Antiviral Drugs, Immunosuppressive Drugs, Corticosteroids, Liver Transplantation, Chemotherapy, Other. ), By Disease (Hepatitis B, Hepatitis C, Non-Alcoholic Fatty Liver Disease (NAFLD), Alcoholic Liver Disease (ALD), Liver Cirrhosis, Other), By Route of Administration (Oral, Injectable, Intravenous, Topical.), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales), and By End-user (Hospitals, Clinics, Homecare Settings, Research Institutions, Pharmaceutical, Other), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Liver Disease Therapeutics Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Rising global prevalence of liver diseases, increasing demand for treatments.

3.2.2. Advancements in treatment options, including antiviral and immunosuppressive therapies.

3.2.3. Growing awareness and government initiatives supporting liver disease management and prevention.

3.3. Key industry pitfalls & challenges

3.3.1. High treatment costs limiting access to therapies in low-income regions.

3.3.2. Limited availability of effective treatments for certain liver conditions.

3.3.3. Stringent regulatory requirements and long approval timelines for new drugs

3.4. Market Opportunities

3.4.1. Increasing demand for non-alcoholic steatohepatitis (NASH) and fibrosis treatments.

3.4.2. Growth in research and development of gene therapies for liver diseases.

3.4.3. Expanding healthcare infrastructure and access in emerging markets globally.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Liver Disease Therapeutics Market, Treatment Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Treatment, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Antiviral Drugs

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Immunosuppressive Drugs

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Corticosteroids

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Liver Transplantation

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Chemotherapy

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7. Other

4.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Liver Disease Therapeutics Market, Disease Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Disease, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Hepatitis B

5.2.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.3. Hepatitis C

5.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.4. Non-Alcoholic Fatty Liver Disease (NAFLD)

5.4.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.5. Alcoholic Liver Disease (ALD)

5.5.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.6. Liver Cirrhosis

5.6.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.7. Other

5.7.1. Market Size and Forecast, By 2025-2035(USD Billion)

6. Liver Disease Therapeutics Market, Route of Administration Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Route of Administration, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Oral

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Injectable

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Intravenous

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Topical

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Liver Disease Therapeutics Market, Distribution Channel Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Hospital Pharmacies

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Retail Pharmacies

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Online Pharmacies

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Direct Sales

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Liver Disease Therapeutics Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Clinics

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Homecare Settings

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Research Institutions

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.6. Pharmaceutical

8.6.1. Market Size and Forecast, 2025-2035 (USD Billion

8.7. Other

8.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Liver Disease Therapeutics Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Treatment, 2025-2035

9.2.3. North America Market Revenue, By Disease, 2025-2035

9.2.4. North America Market Revenue, By Route of Administration, 2025-2035

9.2.5. North America Market Revenue, By Distribution Channel, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Treatment, 2025-2035

9.2.7.2. U.S. Market Revenue, By Disease, 2025-2035

9.2.7.3. U.S. Market Revenue, By Route of Administration, 2025-2035

9.2.7.4. U.S. Market Revenue, By Distribution Channel, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Treatment, 2025-2035

9.2.8.2. Canada Market Revenue, By Disease, 2025-2035

9.2.8.3. Canada Market Revenue, By Route of Administration, 2025-2035

9.2.8.4. Canada Market Revenue, By Distribution Channel, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Treatment, 2025-2035

9.3.3. Europe Market Revenue, By Disease, 2025-2035

9.3.4. Europe Market Revenue, By Route of Administration, 2025-2035

9.3.5. Europe Market Revenue, By Distribution Channel, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Treatment, 2025-2035

9.3.7.2. Germany Market Revenue, By Disease, 2025-2035

9.3.7.3. Germany Market Revenue, By Route of Administration, 2025-2035

9.3.7.4. Germany Market Revenue, By Distribution Channel, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Treatment, 2025-2035

9.3.8.2. France Market Revenue, By Disease, 2025-2035

9.3.8.3. France Market Revenue, By Route of Administration, 2025-2035

9.3.8.4. France Market Revenue, By Distribution Channel, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Treatment, 2025-2035

9.3.9.2. U.K. Market Revenue, By Disease, 2025-2035

9.3.9.3. U.K. Market Revenue, By Route of Administration, 2025-2035

9.3.9.4. U.K. Market Revenue, By Distribution Channel, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Treatment, 2025-2035

9.3.10.2. Italy Market Revenue, By Disease, 2025-2035

9.3.10.3. Italy Market Revenue, By Route of Administration, 2025-2035

9.3.10.4. Italy Market Revenue, By Distribution Channel, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Treatment, 2025-2035

9.3.11.2. Spain Market Revenue, By Disease, 2025-2035

9.3.11.3. Spain Market Revenue, By Route of Administration, 2025-2035

9.3.11.4. Spain Market Revenue, By Distribution Channel, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Treatment, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Disease, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Route of Administration, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Distribution Channel, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Treatment, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Disease, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Route of Administration, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Treatment, 2025-2035

9.4.7.2. China Market Revenue, By Disease, 2025-2035

9.4.7.3. China Market Revenue, By Route of Administration, 2025-2035

9.4.7.4. China Market Revenue, By Distribution Channel, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Treatment, 2025-2035

9.4.8.2. Japan Market Revenue, By Disease, 2025-2035

9.4.8.3. Japan Market Revenue, By Route of Administration, 2025-2035

9.4.8.4. Japan Market Revenue, By Distribution Channel, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Treatment, 2025-2035

9.4.9.2. India Market Revenue, By Disease, 2025-2035

9.4.9.3. India Market Revenue, By Route of Administration, 2025-2035

9.4.9.4. India Market Revenue, By Distribution Channel, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Treatment, 2025-2035

9.4.10.2. Australia Market Revenue, By Disease, 2025-2035

9.4.10.3. Australia Market Revenue, By Route of Administration, 2025-2035

9.4.10.4. Australia Market Revenue, By Distribution Channel, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Treatment, 2025-2035

9.4.11.2. South Korea Market Revenue, By Disease, 2025-2035

9.4.11.3. South Korea Market Revenue, By Route of Administration, 2025-2035

9.4.11.4. South Korea Market Revenue, By Distribution Channel, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Treatment, 2025-2035

9.4.12.2. Singapore Market Revenue, By Disease, 2025-2035

9.4.12.3. Singapore Market Revenue, By Route of Administration, 2025-2035

9.4.12.4. Singapore Market Revenue, By Distribution Channel, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Treatment, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Disease, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Route of Administration, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Treatment, 2025-2035

9.5.3. Latin America Market Revenue, By Disease, 2025-2035

9.5.4. Latin America Market Revenue, By Route of Administration, 2025-2035

9.5.5. Latin America Market Revenue, By Distribution Channel, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Treatment, 2025-2035

9.5.7.2. Brazil Market Revenue, By Disease, 2025-2035

9.5.7.3. Brazil Market Revenue, By Route of Administration, 2025-2035

9.5.7.4. Brazil Market Revenue, By Distribution Channel, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Treatment, 2025-2035

9.5.8.2. Argentina Market Revenue, By Disease, 2025-2035

9.5.8.3. Argentina Market Revenue, By Route of Administration, 2025-2035

9.5.8.4. Argentina Market Revenue, By Distribution Channel, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Treatment, 2025-2035

9.5.9.2. Mexico Market Revenue, By Disease, 2025-2035

9.5.9.3. Mexico Market Revenue, By Route of Administration, 2025-2035

9.5.9.4. Mexico Market Revenue, By Distribution Channel, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Treatment, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Disease, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Route of Administration, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Treatment, 2025-2035

9.6.3. MEA Market Revenue, By Disease, 2025-2035

9.6.4. MEA Market Revenue, By Route of Administration, 2025-2035

9.6.5. MEA Market Revenue, By Distribution Channel, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Treatment, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Disease, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Route of Administration, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Distribution Channel, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Treatment, 2025-2035

9.6.8.2. South Africa Market Revenue, By Disease, 2025-2035

9.6.8.3. South Africa Market Revenue, By Route of Administration, 2025-2035

9.6.8.4. South Africa Market Revenue, By Distribution Channel, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Treatment, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Disease, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Route of Administration, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Distribution Channel, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Gilead Sciences, Inc.

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. AbbVie Inc.

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. Merck & Co., Inc.

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Bristol-Myers Squibb Company

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Novo Nordisk A/S

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. F. Hoffmann-La Roche Ltd.

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Johnson & Johnson

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. GlaxoSmithKline Plc (GSK)

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Hepatitis B Foundation

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. Intercept Pharmaceuticals, Inc.

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Eli Lilly and Company

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Amgen Inc.

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. AstraZeneca Plc

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Bayer AG

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Alexion Pharmaceuticals, Inc.

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis

10.16. Regeneron Pharmaceuticals, Inc.

10.16.1. Business Overview

10.16.2. Financial Performance

10.16.3. Product/Service Offerings

10.16.4. Strategies & recent developments

10.16.5. SWOT Analysis

10.17. Mylan N.V.

10.17.1. Business Overview

10.17.2. Financial Performance

10.17.3. Product/Service Offerings

10.17.4. Strategies & recent developments

10.17.5. SWOT Analysis

10.18. Sanofi S.A.

10.18.1. Business Overview

10.18.2. Financial Performance

10.18.3. Product/Service Offerings

10.18.4. Strategies & recent developments

10.18.5. SWOT Analysis